Advisory and Governance Boards

ICER is fortunate to have the support of a Governance Board and an Advisory Board consisting of national experts in health care policy. The Governance Board has fiduciary responsibility for the overall operations of ICER, while both the Governance Board and Advisory Board provide important strategic counsel to ICER’s leadership team.

ICER Governance Board

Ellen Andrews, PhD, Executive Director, Connecticut Health Policy Project
Carmella Bocchino, RN, MBA, President and CEO, CRB Strategies, LLC
Tanisha Carino, PhD, Executive Director, FasterCures
Wendy Everett, ScD, Special Advisor, NEHI
Ron Pollack, JD, Chair Emeritus, Families USA
Murray Ross, PhD (Chair), Vice President and Director, Kaiser Institute for Health Policy Kaiser Permanente
Lewis Sandy, MD, Executive Vice President, Clinical Advancement, UnitedHealth Group
Mark Skinner, JD, President and CEO, Institute for Policy Advancement
Anya Rader Wallack, PhD, Associate Director, Center for Evidence Synthesis in Health at Brown University
Frances Visco, JD, President, National Breast Cancer Coalition

ICER Advisory Board

Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
Stephen Friedhoff, MD, Senior Vice President, Clinical Strategy and Programs, Anthem, Inc.
Jon Gavras, MD, Senior Vice President, Chief Medical Officer, Prime Therapeutics
Vivian Herrera, Executive Director, Head Immunology & Dermatology and Medical Access, US Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation
Bryan Johnstone, PhD, Vice President, Global HEOR, Sanofi
Andreas Kuznik, Senior Director, Health Economics and Outcomes Research, Regeneron Pharmaceuticals
Carolyn Langer, MD, JD, MPH, Chief Medical Officer, Office of Medicaid (MassHealth) Commonwealth of Massachusetts
Martin Marciniak, PhD, Vice President, US Medical Affairs, Customer Engagement, Value, Evidence, and Outcomes, GlaxoSmithKline
Kendra Martello, JD, Senior Director, Public Policy, Government Affairs & Public Policy, Mallinckrodt Pharmaceuticals
Michael Sherman, MD, MBA, MS, Senior Vice President and Chief Medical Officer, Harvard Pilgrim Health Care
Susan Shiff, PhD, MBA, Senior Vice President, Center for Observational and Real-World Evidence, Merck & Co., Inc.
Sean D. Sullivan, PhD, MSc, Professor and Dean, University of Washington School of Pharmacy
Marcus Thygeson, MD, Chief Health Officer, Bind Benefits
John Watkins, PharmD, MPH, BCPS, Pharmacy Manager, Formulary Development, Premera Blue Cross

 

Program Advisory Boards

CTAF | Midwest CEPAC | New England CEPAC

Each of ICER’s core programs also has a non-governing advisory board. Composed of leading representatives from provider groups, public and private payers, patient groups, and purchasers, the program advisory boards help ensure that all reviews are actionable for a variety of stakeholders.

California Technology Assessment Forum

Wade Aubry, MD, Associate Clinical Professor of Medicine, Philip R. Lee Institute for Health Policy Studies, UCSF
Christine Castano, MD, Medical Director, Utilization Management, HealthCare Partners
Deborah Collyar, Patient Advocates in Research (PAIR)
Meg Durbin, MD, Chief Medical Officer, Canopy Health
Jo Carol Hiatt, MD, MBA, Chair, National Product Council and Assistant Medical Director, SCPMG Business Administration, Kaiser Permanente
Julia Logan, MD, MPH, Chief Quality Officer, California Department of Health Care Services
George Louie, MD, Associate Vice President and Chief Medical Officer for Self-Funded Health Plans, UC Health
Arthur Lurvey, MD, Medicare Contractor Medical Director, Noridian
Robert Plass, MD, MMM, Medical Director, Blue Shield of California
Jeff Rideout, MD, President & CEO, Integrated Healthcare Association (IHA)
Wells Shoemaker, MD, Consulting Medical Director
Kristof Stremikis, MPP, MPH, Director, Market Analysis and Insight, California HealthCare Foundation
Jeff Tice, MD, Associate Professor, UCSF School of Medicine, CTAF Senior Medical Advisor
Lauren Vela, MBA, Senior Director of Member Value, Pacific Business Group on Health
John Yao, MD, MBA, MPH, Staff Vice President of Medical Policy, Anthem

Midwest Comparative Effectiveness Public Advisory Council

Richard Bruzek, PharmD, Vice President, Pharmacy Services, HealthPartners
Harold Carter, PharmD, Director, Clinical Solutions, Express Scripts Holding Company
Andrew Fondow, Director, Health Care & Ancillary Products, Concordia Plan Services
David Heaton, Product Manager, St. Louis Area Business Health Coalition
Ron Laudel, Benefits Plan Administrator, Carpenters’ Benefit Plans Health & Retirement Services
Scott Liebman, Senior Vice President, Aon Hewitt
Jay Moore, MD, Senior Clinical Director, Anthem Blue Cross and Blue Shield
Jason Parrott, Manager, Health Care Policy & Strategy, The Boeing Company
Karen Poston, Manager, Health and Welfare, Graybar Electric
Louise Probst, Executive Director, St. Louis Area Business Health Coalition
Gloria Sachdev, PharmD, President & CEO, Employers’ Forum of Indiana
Scott Spradlin, Chief Medical Officer, Local and Regional Business Unit, Aetna 
Keith Starke, Chief Quality Officer, Mercy Health
Kevin Supple, Chief Financial Officer, Francis Howell School District

New England Comparative Effectiveness Public Advisory Council

Ellen Andrews, PhD, Executive Director, CT Health Policy Project
Peggy Chou, MD, Medical Director, Practice Pattern Variation Department of Quality and Safety, Atrius Health
Mehul Dalal, MD, MSc, MHS, Chronic Disease Director, Community Health and Prevention Section, Connecticut Department of Public Health
Katherine Dallow, MD, MPH, Vice President and Medical Director, Clinical Programs and Strategy, Blue Cross Blue Shield of Massachusetts
Amy Dix, Policy Director, Children’s and Waiver Services, Office of MaineCare Services
Kenneth Duckworth, MD, Medical Director, Behavioral Health, Blue Cross Blue Shield Massachusetts
Teresa Fama, MD, Rheumatologist, Central Vermont Medical Center
Craig Haug, MD, Medical Director, Medicare Part B Policy, NHIC, Corp (Medicare Administrative Contractor)
Nancy Hogue, PharmD, Executive Director of Pharmacy Services, Department of Vermont Health Access
Thomas Isaac, MD, MBA, MPH, Medical Director, Practice Pattern Variation Department of Quality and Safety, Atrius Health
Matthew Katz, MS, Executive Vice President, Chief Executive Officer, Connecticut State Medical Society
Christine Lu, MSc, PhD, Assistant Professor, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
Debra Madden, Cancer Research Advocate, Patient Representative: FDA and ECOG-ACRIN Cancer Research Group
Bill McQuade, D.Sc., MPH, Senior Health Policy Analyst, Rhode Island Executive Office of Health and Human Services, Office of Medicaid
Sandhya Rao, MD, Associate Medical Director, Quality Improvement, Mass General Physicians Organization
Amy Schwartz, MPH, Director, Health Care Cost Containment, University of New Hampshire
Thomas Simpatico, MD, Professor of Psychiatry and Director, Division of Public Psychiatry, The Robert Larner, M.D. College of Medicine at the University of Vermont, Chairman and CEO, MHISSION Translational Systems, LLC
Patricia Toro, MD, MPH, Massachusetts Associate Medical Director, Harvard Pilgrim HealthCare
Robert W. Zavoski, MD, MPH, Medical Director, Connecticut Department of Social Services